Drawing for CERCLE

USPTO serial 97906854

CERCLE

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
WHELAN, JAIME M
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with CERCLE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $697*

Plus Government fees of $375

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

DAVID I. GREENBAUM

DAVID I. GREENBAUM RIMON, P.C.1655 W Fairview Ave, Ste. 102Boise, ID 83702United States

Goods and services

ClassDescriptionStatusFirst use
009downloadable mobile application and computer software utilizing artificial intelligence and machine learning for managing a database to maintain patient healthcare data information for use by healthcare providers in clinical decision-making; downloadable mobile application and computer software utilizing artificial intelligence and machine learning for analyzing data in the field of healthcare for use by healthcare providers in clinical decision-making; downloadable mobile application and computer software utilizing artificial intelligence and machine learning for use by healthcare providers in clinical decision-makingACTIVE—
042Software as a service (SAAS) services featuring non-downloadable software utilizing artificial intelligence and machine learning for managing patient healthcare data, and for managing a database featuring patient healthcare data; software as a service (SAAS) services featuring non-downloadable software utilizing artificial intelligence and machine learning for managing patient healthcare data for use in clinical decision making; software as a service (SAAS) services featuring non-downloadable software utilizing artificial intelligence and machine learning to provide healthcare recommendations to a patient; Software as a service (SAAS) services featuring non-downloadable software featuring data- driven information for patients to understand their health and make informed decisions with their doctors; software as a service (SAAS) services featuring software for use in the collection and analysis of healthcare data and healthcare information; Platform as a service (PaaS) services featuring non-downloadable computer software platforms being data application platform to store and analyze patient data in the healthcare industry; platforms as a service (PaaS) services featuring non-downloadable computer software for creating web applications, data storage and backup, database management, virtualization, networking, collaboration, information access, customer service and support, cloud computing, data sharing, data security, all in the field of healthcare data and healthcare information; platforms as a service (PaaS) services featuring non- downloadable customizable computer software for administration and management of, and distribution and transmission of healthcare data and healthcare information; Computer services, namely, cloud hosting provider services for the healthcare industry; providing online non- downloadable software for database management and data analytics in the healthcare industry; platform as a service (PaaS) services featuring non-downloadable software platform for collecting, analyzing, segmenting, integrating, transforming and providing access to healthcare data and healthcare information; platforms as a service (PaaS) services featuring non- downloadable customizable computer software for collecting, analyzing, segmenting, integrating, transforming and providing access to healthcare data and healthcare information; data as a service (DAAS) services, namely, providing online non-downloadable software for accessing healthcare related data through an electronic computer network; data as a service (DaaS) services, namely, providing online non-downloadable software for use in the collection and analysis of healthcare data and healthcare information; application service provider (ASP) services featuring software for use in the collection and analysis of healthcare data and healthcare information; application service provider featuring non-downloadable application programming interface (API) software for use in the collection and analysis of healthcare data and healthcare information; data as a service (DaaS) services featuring a customizable software platform for collecting, analyzing, integrating, transforming and retrieving healthcare data and healthcare information; software as a service (SAAS) services featuring software featuring healthcare data modeling tools for predictive modeling, profiling, cost containment, quality analyses; software as a service (SaaS) services featuring financial and operational strategies for healthcare providers; all of the aforementioned for use by healthcare providers in clinical decision-making.ACTIVE—
044providing medical information for researchers and laboratory directors to visualize structured data for clinical decision-making; providing medical information for healthcare providers to connect complex, fragmented data for the purpose of treatment optimization and improved patient care, relating to clinical decision-making; providing an on-line searchable database to healthcare providers featuring medical information, medical documentation, anonymized patient medical information in the fields of health, health risk assessments, health risk stratification, health care management, healthcare provider information, lifestyle and personal patient factual information; providing medical and medical clinical data analytics and bioinformatics services to healthcare providers; providing medical and medical clinical data analytics to contextualize biomedical and genomics information to assist healthcare providers in making informed health decisions; providing health risk identification and health risk stratification services to healthcare providers, namely, provision of health reports and health data analysis to identify higher risk conditions and individuals and make recommendations for health care, health care professionals, healthier lifestyles and health improvementACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 11, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 26, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 1, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 1, 2026ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jul 1, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 15, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 14, 2026EX1GSOU EXTENSION 1 GRANTED—
Jan 14, 2026EXT1SOU EXTENSION 1 FILED—
Jan 14, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 15, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 20, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 20, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 14, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 21, 2025EXPTEXPARTE APPEAL TERMINATED—
Apr 21, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2025ALIEASSIGNED TO LIE—
Mar 14, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 14, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 5, 2025EXPIEX PARTE APPEAL-INSTITUTED—
Mar 5, 2025JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Mar 5, 2025EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Mar 4, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Dec 4, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Dec 4, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Sep 4, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 4, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 4, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 8, 2024AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Aug 8, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Aug 2, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 1, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 1, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 1, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
May 1, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 1, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2024DOCKASSIGNED TO EXAMINER—
May 23, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 28, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance